Steroids in Septic Shock
========================

##### Summary

In early septic shock, IV steroid boluses possibly reduce mortality, but likely improve secondary patient-centred outcomes of ventilator-free days, LOS in the ICU, vasopressor dependence.

Reasonable to initiate hydrocortisone boluses for patients in septic shock that is refractory to initial vasopressor therapy.

*   Accelerates resolution of shock by 1.5 days
*   Increases vasopressor-free days by 1.5 days
*   Increases neuromuscular weakness
*   No clear effect on short or long-term mortality

#### Dosing

\- Typical regimen: IV hydrocortisone 50 mg q.6h or 200 mg/d continuous infusion  
\- Unclear optimal regimen, most studies used the above dosing regimen.  
\- Duration was 7 days in APROCCHSS, 5 days with 6 day taper in VANISH.  
Unclear whether there's a dose response benefit

#### Mortality benefit studies

[![image-1639003231516.png](http://150.230.28.46:8080/uploads/images/gallery/2021-12/scaled-1680-/o5eIZri5H8S4SmUk-image-1639003231516.png)](http://150.230.28.46:8080/uploads/images/gallery/2021-12/o5eIZri5H8S4SmUk-image-1639003231516.png)

#### No Mortality Benefit

[![image-1639003241634.png](http://150.230.28.46:8080/uploads/images/gallery/2021-12/scaled-1680-/wbIKy57tmwpmCSfY-image-1639003241634.png)](http://150.230.28.46:8080/uploads/images/gallery/2021-12/wbIKy57tmwpmCSfY-image-1639003241634.png)

#### Primary Literature

1. VANISH - Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA. 2016;316(5):509-518. doi:10.1001/jama.2016.10485

2. APROCCHSS - Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. New England Journal of Medicine. 2018;378(9):809-818. doi:10.1056/NEJMoa1705716  

3. ADRENAL - Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. New England Journal of Medicine. 2018;378(9):797-808. doi:10.1056/NEJMoa1705835  

4. French trial - Annane D, SÃ©bille V, Charpentier C, et al. Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock. JAMA. 2002;288(7):862-871. doi:10.1001/jama.288.7.862
